504 related articles for article (PubMed ID: 17558743)
1. Targeting costimulatory pathways for tumor immunotherapy.
Ward RC; Kaufman HL
Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
[TBL] [Abstract][Full Text] [Related]
2. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
3. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
4. The B7 family and cancer therapy: costimulation and coinhibition.
Zang X; Allison JP
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5271-9. PubMed ID: 17875755
[TBL] [Abstract][Full Text] [Related]
5. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
6. Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein.
Blanco B; Holliger P; Alvarez-Vallina L
Cancer Gene Ther; 2002 Mar; 9(3):275-81. PubMed ID: 11896444
[TBL] [Abstract][Full Text] [Related]
7. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
Liu A; Hu P; Khawli LA; Epstein AL
J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
[TBL] [Abstract][Full Text] [Related]
8. Regulation of TCR-mediated T cell activation by TNF-RII.
Aspalter RM; Eibl MM; Wolf HM
J Leukoc Biol; 2003 Oct; 74(4):572-82. PubMed ID: 12960285
[TBL] [Abstract][Full Text] [Related]
9. T lymphocyte co-signaling pathways of the B7-CD28 family.
Wang S; Chen L
Cell Mol Immunol; 2004 Feb; 1(1):37-42. PubMed ID: 16212919
[TBL] [Abstract][Full Text] [Related]
10. The new B7s: playing a pivotal role in tumor immunity.
Flies DB; Chen L
J Immunother; 2007 Apr; 30(3):251-60. PubMed ID: 17414316
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
Allen SD; Rawale SV; Whitacre CC; Kaumaya PT
J Pept Res; 2005 Jun; 65(6):591-604. PubMed ID: 15885118
[TBL] [Abstract][Full Text] [Related]
12. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
Lynch DH
Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
[TBL] [Abstract][Full Text] [Related]
13. High-affinity small molecule inhibitors of T cell costimulation: compounds for immunotherapy.
Huxley P; Sutton DH; Debnam P; Matthews IR; Brewer JE; Rose J; Trickett M; Williams DD; Andersen TB; Classon BJ
Chem Biol; 2004 Dec; 11(12):1651-8. PubMed ID: 15610849
[TBL] [Abstract][Full Text] [Related]
14. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.
Chin LT; Chu C; Chen HM; Wang DW; Liao SK
Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T-lymphocyte-associated antigen-4.
Hodi FS
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5238-42. PubMed ID: 17875750
[TBL] [Abstract][Full Text] [Related]
16. Principles of tumor immunosurveillance and implications for immunotherapy.
Ochsenbein AF
Cancer Gene Ther; 2002 Dec; 9(12):1043-55. PubMed ID: 12522443
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
19. Future directions for immunotherapeutic intervention against sarcomas.
Maki RG
Curr Opin Oncol; 2006 Jul; 18(4):363-8. PubMed ID: 16721132
[TBL] [Abstract][Full Text] [Related]
20. Imaging the immune response to monitor tumor immunotherapy.
Wang Q; Ornstein M; Kaufman HL
Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
